Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  561 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Subject : diabetic nephropathies
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Potential kidney protective effects of glucagon-like peptide-1 receptor agonists.

  • Authors : Trevella P; Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.; Ekinci EI

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Aug; Vol. 29 (8), pp. 457-469. Date of Electronic Publication: 2024 Jun 20.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Aug; Vol. 26 (8), pp. 3248-3260. Date of Electronic Publication: 2024 May 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[GLP-1 receptor agonists : impact on diabetic kidney disease].

  • Authors : Wéra M; Service de diabétologie, nutrition et maladies métaboliques, Centre hospitalier universitaire de Liège, 4000 Liège, Belgique.; Paquot N

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Revue medicale suisse [Rev Med Suisse] 2024 Aug 28; Vol. 20 (884), pp. 1488-1491.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?

  • Authors : Bonnet F; Department of Diabetology, CHU de Rennes, Université de Rennes 1, Rennes, France.; Cooper ME

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Nov; Vol. 26 Suppl 6, pp. 55-65. Date of Electronic Publication: 2024 Jun 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1 RAs and SGLT2-Is to Lower Glucose and Reduce the Risk of Cardiovascular and Diabetic Kidney Disease.

  • Authors : Morrison L; From the Clinical Assistant Professor, Department of Family Medicine, University of Michigan (LM, JG); Associate Professor, Department of Family Medicine, University of Michigan (LO). .

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Journal of the American Board of Family Medicine : JABFM [J Am Board Fam Med] 2024 May-Jun; Vol. 37 (3), pp. 372-382.Publisher: American Board of Family Medicine Country of Publication: United States NLM ID: 101256526 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression.

  • Authors : Holliday MW Jr; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine.; Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

  • Source: Current opinion in nephrology and hypertension [Curr Opin Nephrol Hypertens] 2024 May 01; Vol. 33 (3), pp. 331-336. Date of Electronic Publication: 2024 Feb 23.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9303753 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Role of GLP-1 Receptor Agonist in Diabetic Cardio-renal Disorder: Recent Updates of Clinical and Pre-clinical Evidence.

  • Authors : Seksaria S; Department of Pharmacology, ISF College of Pharmacy, GT Road, GhalKalan, Moga 142001, Punjab, India.; Department of Pharmacy, Sanaka Educational Trust's Group of Institutions, Malandighi, Durgapur 713212, India.

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Current diabetes reviews [Curr Diabetes Rev] 2024; Vol. 20 (6), pp. e090823219597.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101253260 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease.

  • Authors : Lin Y; Department of Emergency Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.; Chang Gung University, Taoyuan, Taiwan.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/diagnosis ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Mar 17; Vol. 22 (1), pp. 60. Date of Electronic Publication: 2023 Mar 17.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.

  • Authors : Sloan LA; Texas Institute for Kidney and Endocrine Disorders, Lufkin, Texas.; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists

  • Source: Journal of diabetes [J Diabetes] 2019 Dec; Vol. 11 (12), pp. 938-948. Date of Electronic Publication: 2019 Aug 14.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients.

  • Authors : Kim MK; Division of Endocrinology, Department of Internal Medicine, Hallym University College of Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.; Kim DM

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*prevention & control ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2021 Jun; Vol. 12 (6), pp. 914-916. Date of Electronic Publication: 2021 May 07.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  561 results for ""GLUCAGON-like peptide-1 receptor""